Monday, November 18, 2024
HomeTagsRare cancers

rare cancers

MTTI and Monrol Have Signed a Clinical Supply Agreement for Lu-177 n.c.a

Eczacıbaşı-Monrol Nuclear Products Co. (Monrol) today announced their agreement with Molecular Targeting Technologies, Inc. (MTTI), a clinical stage biotech company focused on developing innovative...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics